Aqr Capital Management LLC Wave Life Sciences Ltd. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Aqr Capital Management LLC holds 23,945 shares of WVE stock, worth $322,778. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,945

Previous 33,529 28.58%

Holding current value

$322,778

Previous $167,000 17.37%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.12 - $9.01 $49,070 - $86,351	-9,584 Reduced 28.58%	23,945 $196,000
Q2 2024 Aug 14, 2024	BUY	$4.38 - $6.48 $30,541 - $45,185	6,973 Added 26.26%	33,529 $167,000
Q1 2024 May 15, 2024	BUY	$3.54 - $6.84 $54,473 - $105,253	15,388 Added 137.79%	26,556 $163,000
Q4 2023 Feb 14, 2024	BUY	$4.16 - $6.87 $395 - $652	95 Added 0.86%	11,168 $56,000
Q3 2023 Nov 14, 2023	BUY	$3.56 - $5.75 $39,419 - $63,669	11,073 New	11,073 $63,000
Q1 2022 May 16, 2022	SELL	$2.0 - $3.28 $155,122 - $254,400	-77,561 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.14 - $5.15 $243,541 - $399,439	77,561 New	77,561 $244,000
Q2 2021 Aug 16, 2021	SELL	$5.65 - $7.47 $226,327 - $299,233	-40,058 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$5.61 - $12.01 $103,549 - $221,680	-18,458 Reduced 31.54%	40,058 $225,000
Q4 2020 Feb 16, 2021	BUY	$6.99 - $9.26 $409,026 - $541,858	58,516 New	58,516 $461,000
Q1 2019 May 14, 2019	SELL	$32.69 - $47.91 $412,678 - $604,815	-12,624 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$37.1 - $50.11 $44,668 - $60,332	-1,204 Reduced 8.71%	12,624 $531,000
Q3 2018 Nov 15, 2018	BUY	$36.35 - $55.2 $107,087 - $162,619	2,946 Added 27.07%	13,828 $691,000
Q2 2018 Aug 14, 2018	BUY	$33.85 - $50.65 $368,355 - $551,173	10,882 New	10,882 $416,000

Others Institutions Holding WVE

# of Institutions

164

Shares Held

117M

Call Options Held

148K

Put Options Held

109K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.17B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Wave Life Sciences Ltd. Transaction History